Ubs Global Asset Management Americas »

Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 3.0M 0.99
2023-09-30 $3.0M 3.0M 0.98
2023-06-30 $2.5M 3.0M 0.83
2023-03-31 $2.5M 3.0M 0.83

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Ubs Global Asset Management Americas

View all funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd